|
|
H2004/149 (13757)/R1
|
Dopamine HCl Fresenius Solution for Infusion
|
Dopamine Hydrochloride
|
Fresenius Kabi Manufacturing SA (Pty) Limited
|
Retained
|
Details →
|
|
|
H2015/CTD2680/354
|
KABIVEN
|
1000 ML OF MIXED SOLUTION CONTAINS: GLUCOSE MONOHYDRATE (CORRESP. TO GLUCOSE ANHYDROUS), PURIFIED SOYBEAN OIL, L-ALANINE, L-ARGININE, L-ASPARTIC ACID, L-GLUTAMIC ACID, GLYCINE, L-HISTIDINE, L-ISOLEUCINE, L-LEUCINE, L-LYSIN
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
14767, H2005/184
|
KABIVEN PERIPHERAL
|
1000 ML OF MIXED SOLUTION CONTAINS: GLUCOSE MONOHYDRATE (CORRESP. TO GLUCOSE ANHYD.), PURIFIED SOYBEAN OIL, L-ALANINE, L-ARGININE L-ASPARTIC ACID, L-GLUTAMIC ACID, GLYCINE, L-HI...
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2003/130 (14380)
|
SUXAMETHONIUM CHLORIDE FRESENIUS 100 MG/2 ML
|
SUXAMETHONIUM CHLORIDE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
14168
|
THIOPENTONE SODIUM FRESENIUS 0.5G/20ML
|
THIOPENTAL SODIUM
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
CTD4100
|
FRESENIUS PROPOVEN 1 %
|
PROPOFOL
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2022/CTD4100/10517ER
|
FRESENIUS PROPOVEN 1 %
|
PROPOFOL
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2020/CTD5150/1711ER
|
ONDANSETRON FRESENIUS 2 MG/ML
|
ONDANSETRON HYDROCHLORIDE DIHYDRATE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
CTD3246
|
PARACETAMOL FRESENIUS 10 MG/ML
|
PARACETAMOL
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
7547, H92/014
|
AMINOSTERIL KE 10% CARBOHYDRATE FREE
|
L-ISOLEUCINE L-LEUCINE L-LYSINE L-METHIONINE L-PHENYLALANINE L-THREONINE L-TRYPTOPHAN L-VALINE L-ARGININE L-HISTIDINE GLYCINE L-ALANINE L-PROLINE L-MALIC ACID
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2015/CTD2506/539/R1
|
SMOFKabiven
|
1000 ml of mixed solution contains: Glucose (as…
|
Fresenius Kabi South Africa (Pty) Limited
|
Retained
|
Details →
|
|
|
H2015/CTD2505/538/R1
|
SMOFKabiven Peripheral
|
1000 ml of mixed solution contains: Glucose (as…
|
Fresenius Kabi South Africa (Pty) Limited
|
Retained
|
Details →
|
|
|
H2008/7124/R1
|
NEPHROSTERIL
|
1000 ML SOLUTION OF INFUSION CONTAIN: L-ISOLEUCINE L-LEUCINE L-LYSINE MONOACETATE (COR. L-LYSINE) L-METHIONINE ACETYLCYSTEINE (L-CYSTEINE) L-PHENYLALANINE L-THREONINE L-TRYPTOPHAN L-VALINE L-ARGININE L-HISTIDINE GLYCINE L-ALANINE L-PROLINE L-SE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2001/0235
|
KEMOCARB INJECTION
|
CARBOPLATIN
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
H2001/0235/R1
|
Kemocarb Injection
|
Carboplatin
|
Fresenius Kabi Oncology Limited
|
Retained
|
Details →
|
|
|
H2022/CTD6841/13040
|
ADDAVEN
|
CHROMIC CHLORIDE HEXAHYDRATE, COPPER CHLORIDE DIHYDRATE, FERRIC CHLORIDE HEXAHYDRATE, MANGANESE CHLORIDE TETRAHYDRATE, POTASSIUM IODIDE, SODIUM FLUORIDE, SODIUM MOLYBDATE DIHYDRATE, SODIUM SELENITE ANHYDROUS, ZINC CHLORIDE
|
SURGIPHARM LTD
|
Registered
|
Details →
|
|
|
H2022/CTD8522/16925
|
OXITAN INJECTION CONCENTRATE
|
OXALIPLATIN
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|
|
|
12165
|
HAES-STERIL 6%
|
HYDROXYETHYLSTARCH 200/0.5
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2022/CTD8612/16927
|
DAXOTEL INJECTION CONCENTRATE
|
DOCETAXEL (ANHYDROUS)
|
NAIROBI ENTERPRISES LTD
|
Registered
|
Details →
|